About: Recombinant vaccines against the mononegaviruses—What we have learned from animal disease controls

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Recombinant vaccines against the mononegaviruses—What we have learned from animal disease controls Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Recombinant vaccines against the mononegaviruses—What we have learned from animal disease controls
Creator	Honda, Tomoyuki Kai, Chieko Sato, Hiroki Yoneda, Misako
Source	Elsevier; Medline; PMC
abstract	Abstract The mononegaviruses include a number of highly contagious and severe disease-causing viruses of both animals and humans. For the control of these viral diseases, development of vaccines, either with classical methods or with recombinant DNA virus vectors, has been attempted over the years. Recently reverse genetics of mononegaviruses has been developed and used to generate infectious viruses possessing genomes derived from cloned cDNA in order to study the consequent effects of viral gene manipulations on phenotype. This technology allows us to develop novel candidate vaccines. In particular, a variety of different attenuation strategies to produce a range of attenuated mononegavirus vaccines have been studied. In addition, because of their ideal nature as live vaccines, recombinant mononegaviruses expressing foreign proteins have also been produced with the aim of developing multivalent vaccines against more than one pathogen. These recombinant mononegaviruses are currently under evaluation as new viral vectors for vaccination. Reverse genetics could have great potential for the preparation of vaccines against many mononegaviruses.
has issue date	2011-12-31(xsd:dateTime)
bibo:doi	10.1016/j.virusres.2011.09.038
bibo:pmid	21982973
has license	els-covid
sha1sum (hex)	ed64e6c43246b10eea3b236a206e5f25d37ab564
schema:url	https://doi.org/10.1016/j.virusres.2011.09.038
resource representing a document's title	Recombinant vaccines against the mononegaviruses—What we have learned from animal disease controls
has PubMed Central identifier	PMC7114506
has PubMed identifier	21982973
schema:publication	Virus Research
resource representing a document's body	covid:ed64e6c43246b10eea3b236a206e5f25d37ab564#body_text
is schema:about of	named entity 'RECOMBINANT VACCINES' named entity 'attenuated' named entity 'vaccines' named entity 'order' named entity 'number' named entity 'developing' named entity 'LEARNED' named entity 'STRATEGIES' named entity 'PREPARATION' named entity 'PATHOGEN' named entity 'ORDER' named entity 'PHENOTYPE' named entity 'MANIPULATIONS' named entity 'VIRAL GENE' named entity 'INFECTIOUS' named entity 'TO PRODUCE' named entity 'MORE THAN ONE' named entity 'TECHNOLOGY' named entity 'FOREIGN' named entity 'CANDIDATE' named entity 'ALLOWS' named entity 'VECTORS' covid:arg/ed64e6c43246b10eea3b236a206e5f25d37ab564 named entity 'ADDITION' named entity 'CLASSICAL' named entity 'VACCINES' named entity 'INCLUDE' named entity 'ATTENUATION' named entity 'YEARS' named entity 'SEVERE DISEASE' named entity 'VIRUSES' named entity 'NATURE' named entity 'DNA VIRUS' named entity 'DERIVED' named entity 'POTENTIAL' named entity 'GREAT' named entity 'PARTICULAR' named entity 'EFFECTS' named entity 'CONSEQUENT' named entity 'VARIETY' named entity 'PROTEINS' named entity 'THEIR' named entity 'CAUSING' named entity 'THESE' named entity 'CLONED' named entity 'DEVELOPING' named entity 'NOVEL' named entity 'RANGE' named entity 'DEVELOPMENT' named entity 'NEW' named entity 'HAVE' named entity 'ANIMAL DISEASE' named entity 'AIM' named entity 'VIRAL VECTORS' named entity 'GENERATE' named entity 'EITHER' named entity 'EVALUATION' named entity 'GENOMES' named entity 'DIFFERENT' named entity 'USED' named entity 'METHODS' named entity 'HUMANS' named entity 'ATTEMPTED' named entity 'RECOMBINANT' named entity 'VIRAL DISEASES' named entity 'ANIMALS' named entity 'VACCINATION' named entity 'HIGHLY' named entity 'CDNA' named entity 'STUDY' named entity 'CURRENTLY' named entity 'RECENTLY' named entity 'RECOMBINANT DNA' named entity 'LIVE VACCINES' named entity 'NUMBER OF' named entity 'IDEAL' named entity 'REVERSE GENETICS' named entity 'HAVE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software